Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guozhi Tang

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Medicinal Chemistry|October 13, 2006
Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteinsGuoping Wang, Zaneta Nikolovska-Coleska, Chao-Yie Yang, et al.
Journal of Medicinal Chemistry|June 26, 2020
EEDi-5285: An Exceptionally Potent, Efficacious, and Orally Active Small-Molecule Inhibitor of Embryonic Ectoderm DevelopmentRohan Kalyan Rej, Changwei Wang, Jianfeng Lu, et al.
Journal of Medicinal Chemistry|July 27, 2016
Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|October 16, 2012
Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor responseJason C Wong, Guozhi Tang, Xihan Wu, et al.
Journal of Medicinal Chemistry|March 25, 2017
Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Weixing Zhang, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Medicinal Chemistry|October 13, 2006
Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteinsGuoping Wang, Zaneta Nikolovska-Coleska, Chao-Yie Yang, et al.
Journal of Medicinal Chemistry|June 26, 2020
EEDi-5285: An Exceptionally Potent, Efficacious, and Orally Active Small-Molecule Inhibitor of Embryonic Ectoderm DevelopmentRohan Kalyan Rej, Changwei Wang, Jianfeng Lu, et al.
Journal of Medicinal Chemistry|July 27, 2016
Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|October 16, 2012
Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor responseJason C Wong, Guozhi Tang, Xihan Wu, et al.
Journal of Medicinal Chemistry|March 25, 2017
Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Weixing Zhang, et al.
Pageof 3